|
FNIP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.26310003859487E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.86290000092626E-08 |
| Normal-vs-Stage2 |
2.66159999995352E-06 |
| Normal-vs-Stage3 |
7.43400000446925E-08 |
| Normal-vs-Stage4 |
1.93309999996227E-06 |
| Stage1-vs-Stage2 |
6.828200E-01 |
| Stage1-vs-Stage3 |
6.340800E-01 |
| Stage1-vs-Stage4 |
5.109400E-01 |
| Stage2-vs-Stage3 |
9.585000E-01 |
| Stage2-vs-Stage4 |
8.425200E-01 |
| Stage3-vs-Stage4 |
7.811400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11930001220639E-09 |
| Normal-vs-AfricanAmerican |
3.737100E-03 |
| Normal-vs-Asian |
1.72957999999834E-05 |
| Caucasian-vs-AfricanAmerican |
4.501000E-01 |
| Caucasian-vs-Asian |
9.134600E-01 |
| AfricanAmerican-vs-Asian |
4.571400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68849999537812E-08 |
| Normal-vs-Female |
3.36490002528222E-09 |
| Male-vs-Female |
3.982600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.52269999965338E-07 |
| Normal-vs-Age(41-60Yrs) |
1.22030052729372E-10 |
| Normal-vs-Age(61-80Yrs) |
9.46699999948564E-07 |
| Normal-vs-Age(81-100Yrs) |
1.684710E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.909410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.323600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.120000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.300600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.656400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.615400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.836800E-01 |
| Classical-VS-Follicular |
1.981620E-01 |
| Classical-VS-Other |
1.753440E-01 |
| Classical-VS-Normal |
7.02329999713314E-08 |
| Tall-VS-Follicular |
5.890600E-01 |
| Tall-VS-Other |
1.729440E-01 |
| Tall-VS-Normal |
1.583990E-04 |
| Follicular-VS-Other |
3.312000E-01 |
| Follicular-VS-Normal |
4.13480000238664E-08 |
| Other-VS-Normal |
1.263890E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.08960010090232E-10 |
| Normal-vs-N1 |
4.53990000004456E-06 |
| N0-vs-N1 |
9.969800E-01 |
|
|
